Terns Pharmaceuticals (TERN) Q1 2026 Earnings

Mar 30Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.29
-0.28
-0.27
-0.26

Details

Expected EPS
-0.287778
Actual EPS
-0.27
Surprise EPS
0.02
Surprise Percent
+6.18%

Description

⁨Terns Pharmaceuticals⁩ (⁦TERN⁩) has reported earnings of ⁦-0.27⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts